MedPath

Prediction of outcome in acute pancreatitis by the qSOFA and the new ERAP score

Conditions
K85.0
Idiopathic acute pancreatitis
Registration Number
DRKS00023141
Lead Sponsor
II. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar der TU München
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
203
Inclusion Criteria

Patients with acute pancreatitis

Exclusion Criteria

symptoms started > 72 hours before admission, analgosedation, intubation or therapy with vasopressors at admission or referral, pregnancy

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary objective of this study is to analyze the potential of the qSOFA score to predict severity, need for intensive care treatment, development of MODS and mortality in patients with acute pancreatitis. qSOFA is routinely calculated for every patient when presenting to the emergency department
Secondary Outcome Measures
NameTimeMethod
Secondary objective is the comparison of the prognostic potential of qSOFA to established scores including Ranson-, BISAP- and SOFA score as well as laboratory markers including C-reactive protein (CRP), blood urea nitrogen (BUN) and hematocrit. <br>Tertiary objective is the evaluation of a combination of rapidly available established prognostic parameters with the qSOFA score and if required validation in a retrospective patient cohort. <br>
© Copyright 2025. All Rights Reserved by MedPath